Brown Advisory’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Brown Advisory’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-60,772	Closed	-$6.04M	–	1403
2018 Q2	$6.04M	Sell	60,772 -9,372	-13%	-$810K	0.02%	405
2018 Q1	$5.68M	Hold	70,144	–	–	0.02%	380
2017 Q4	$5.53M	Hold	70,144	–	–	0.02%	394
2017 Q3	$6.47M	Sell	70,144 -132	-0.2%	-$12.7K	0.02%	357
2017 Q2	$7.95M	Buy	70,276 +33,771	+93%	+$3.77M	0.02%	345
2017 Q1	$3.65M	Buy	+36,505	New	+$3.9M	0.01%	427

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory's CBPO Position: Q3 2018 in Review

Brown Advisory sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 60,772 shares — an estimated $6.04M sold.

Brown Advisory first reported a position in CBPO in Q1 2017 and held it in 6 quarters. The position peaked at $7.95M in Q2 2017. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Brown Advisory reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Brown Advisory sold 60,772 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $6.04M.
Brown Advisory first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 6 quarters.
Brown Advisory's China Biologic Products Holdings, Inc. position peaked at $7.95M in Q2 2017.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Brown Advisory's 13F filing for Q3 2018, filed 13 Nov 2018.